Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Zero Point Five Therapeutics

HQ: Baltimore, MD source · zeropointfivetherapeutics.com ↗

Clinical Phase 3

Location: Baltimore, MD · source · Apr 17, 2025

Profile checked Oct 10, 2026

Keywords: Soil-Transmitted Helminthiasis

1Trials (company is sponsor)

Timeline

Feb 14, 2025 Trial start 3: Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH source ↗

Upcoming milestones

Mar 1, 2027 (ESTIMATED) · 3 · Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH) · NCT06128447

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT06128447	Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH)	3	Recruiting	Feb 14, 2025	Mar 1, 2027 (estimated)